Literature DB >> 27294278

Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it.

Guido Torzilli1, Luca Viganò2, Felice Giuliante3, Antonio Daniele Pinna4.   

Abstract

During the last decades, liver surgery had an extraordinary evolution and diffusion thanks to a drastic reduction of operative mortality and morbidity rates. A debate is ongoing about the need for centralization of liver resections in tertiary referral centers. Robust evidences showed that complex surgical procedures have lower mortality rates when performed in high-volume centers. The present expert group reviewed the literature data and proposed guidelines to identify surgical units that should be entitled to perform liver surgery in Italy. Three separate types of requirements were identified. First, the hospital requirements that include the following criteria: (1) a hospital of 1st level according to the Italian law; (2) the presence of a dedicated hepatobiliary or hepatobiliopancreatic unit or a team dedicated to liver surgery into a general surgery unit; (3) the mandatory presence of oncology, hepatology, radiology, interventional radiology, digestive endoscopy, intensive care, and pathology units; (4) the availability of a liver transplant team into the hospital or into another hospital within an established partnership; (5) a periodic multidisciplinary meeting. Second, the volume requirements: the unit has to perform more than 20 liver resections per year for malignant liver diseases with a 90-day mortality rate < 3 %. Finally, the organization requirements: the presence of specific diagnostic-therapeutic flowcharts for liver diseases.

Entities:  

Keywords:  Centralization; Hospital volume; Liver surgery; Minimal requirements; Mortality and morbidity; Multidisciplinary team

Mesh:

Year:  2016        PMID: 27294278     DOI: 10.1007/s13304-016-0373-0

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  32 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 2.  A systematic review of the impact of volume of hepatic surgery on patient outcome.

Authors:  Giuseppe Garcea; Stephanie O Breukink; Nicholas E Marlow; Guy J Maddern; Bruce Barraclough; Neil A Collier; Ian C Dickinson; Jonathon Fawcett; John C Graham
Journal:  Surgery       Date:  2009-03-21       Impact factor: 3.982

3.  Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact.

Authors:  Luca Viganò; Laura Rubbia-Brandt; Giovanni De Rosa; Pietro Majno; Serena Langella; Christian Toso; Gilles Mentha; Lorenzo Capussotti
Journal:  Ann Surg Oncol       Date:  2015-04-07       Impact factor: 5.344

4.  Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.

Authors:  Luca Viganò; Serena Langella; Alessandro Ferrero; Nadia Russolillo; Elisa Sperti; Lorenzo Capussotti
Journal:  Ann Surg Oncol       Date:  2012-09-26       Impact factor: 5.344

5.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

6.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

7.  Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database.

Authors:  Justin B Dimick; John A Cowan; James A Knol; Gilbert R Upchurch
Journal:  Arch Surg       Date:  2003-02

8.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

9.  One thousand fifty-six hepatectomies without mortality in 8 years.

Authors:  Hiroshi Imamura; Yasuji Seyama; Norihiro Kokudo; Atsushi Maema; Yasuhiko Sugawara; Keiji Sano; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2003-11

10.  One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach.

Authors:  Guido Torzilli; Fabio Procopio; Florin Botea; Matteo Marconi; Daniele Del Fabbro; Matteo Donadon; Angela Palmisano; Antonino Spinelli; Marco Montorsi
Journal:  Surgery       Date:  2009-07       Impact factor: 3.982

View more
  6 in total

1.  Contemporary practice and short-term outcomes after liver resections in a complete national cohort.

Authors:  Kristoffer Lassen; Linn Såve Nymo; Frank Olsen; Kristoffer Watten Brudvik; Åsmund Avdem Fretland; Kjetil Søreide
Journal:  Langenbecks Arch Surg       Date:  2018-12-05       Impact factor: 3.445

2.  The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology.

Authors:  Aldo Rocca; Federica Cipriani; Paolo Delrio; Fulvio Calise; Luca Aldrighetti; Giulio Belli; Stefano Berti; Ugo Boggi; Vincenzo Bottino; Umberto Cillo; Matteo Cescon; Matteo Cimino; Francesco Corcione; Luciano De Carlis; Maurizio Degiuli; Paolo De Paolis; Agostino Maria De Rose; Domenico D'Ugo; Fabrizio Di Benedetto; Ugo Elmore; Giorgio Ercolani; Giuseppe M Ettorre; Alessandro Ferrero; Marco Filauro; Felice Giuliante; Salvatore Gruttadauria; Alfredo Guglielmi; Francesco Izzo; Elio Jovine; Andrea Laurenzi; Francesco Marchegiani; Pierluigi Marini; Marco Massani; Vincenzo Mazzaferro; Michela Mineccia; Francesco Minni; Andrea Muratore; Simone Nicosia; Riccardo Pellicci; Riccardo Rosati; Nadia Russolillo; Antonino Spinelli; Gaya Spolverato; Guido Torzilli; Giovanni Vennarecci; Luca Viganò; Leonardo Vincenti
Journal:  Updates Surg       Date:  2021-06-05

Review 3.  Effects of volume on outcome in hepatobiliary surgery: a review with guidelines proposal.

Authors:  Eloisa Franchi; Matteo Donadon; Guido Torzilli
Journal:  Glob Health Med       Date:  2020-10-31

4.  First 100 minimally invasive liver resections in a new tertiary referral centre for liver surgery.

Authors:  Giuliano La Barba; Leonardo Solaini; Giorgia Radi; Maria Teresa Mirarchi; Fabrizio D'Acapito; Andrea Gardini; Alessandro Cucchetti; Giorgio Ercolani
Journal:  J Minim Access Surg       Date:  2022 Jan-Mar       Impact factor: 1.407

5.  COVID-19 and Liver Surgery: How the Pandemic Affected an Italian Medium-Volume HBP Center.

Authors:  Francesca Carissimi; Mauro Alessandro Scotti; Cristina Ciulli; Alessandro Fogliati; Fabio Uggeri; Marco Chiarelli; Marco Braga; Fabrizio Romano; Mattia Garancini
Journal:  Front Surg       Date:  2022-06-28

6.  Volume-outcome relationship of liver surgery: a nationwide analysis.

Authors:  P B Olthof; A K E Elfrink; E Marra; E J T Belt; P B van den Boezem; K Bosscha; E C J Consten; M den Dulk; P D Gobardhan; J Hagendoorn; T N T van Heek; J N M IJzermans; J M Klaase; K F D Kuhlmann; W K G Leclercq; M S L Liem; E R Manusama; H A Marsman; J S D Mieog; S J Oosterling; G A Patijn; W Te Riele; R-J Swijnenburg; H Torrenga; P van Duijvendijk; M Vermaas; N F M Kok; D J Grünhagen
Journal:  Br J Surg       Date:  2020-03-24       Impact factor: 6.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.